Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Sullivan

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expressionNills Diaz, Susan Minton, Charles Cox, et al.
Urology|June 24, 2024
Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center ExperienceNassib Abou Heidar, Abdul Wasay Mahmood, Mohammad Khan, et al.
Oral Oncology|January 24, 2026
Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysisNeil D Almeida, Tyler V Schrand, Daniel Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cellsTanya Gritsko, Ann Williams, James Turkson, et al.
Viruses|September 28, 2023
Recurring Trans-Atlantic Incursion of Clade 2.3.4.4b H5N1 Viruses by Long Distance Migratory Birds from Northern Europe to Canada in 2022/2023Tamiru N Alkie, Alexander M P Byrne, Megan E B Jones, et al.
ACS Applied Materials & Interfaces|November 4, 2020
Tunable Electrical Properties of Embossed, Cellulose-Based Paper for Skin-like SensingTongfen Liang, Xiyue Zou, Ramendra Kishor Pal, et al.
Investigational New Drugs|March 18, 2015
Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignanciesDavid C Smith, Thea Kalebic, Jeffrey R Infante, et al.
RMD Open|November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung diseaseSangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
Blood|January 17, 2004
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myelomaMelissa Alsina, Rafael Fonseca, Edward F Wilson, et al.
Blood|December 18, 2012
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomibPaul G Richardson, David Siegel, Rachid Baz, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expressionNills Diaz, Susan Minton, Charles Cox, et al.
Urology|June 24, 2024
Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center ExperienceNassib Abou Heidar, Abdul Wasay Mahmood, Mohammad Khan, et al.
Oral Oncology|January 24, 2026
Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysisNeil D Almeida, Tyler V Schrand, Daniel Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cellsTanya Gritsko, Ann Williams, James Turkson, et al.
Viruses|September 28, 2023
Recurring Trans-Atlantic Incursion of Clade 2.3.4.4b H5N1 Viruses by Long Distance Migratory Birds from Northern Europe to Canada in 2022/2023Tamiru N Alkie, Alexander M P Byrne, Megan E B Jones, et al.
ACS Applied Materials & Interfaces|November 4, 2020
Tunable Electrical Properties of Embossed, Cellulose-Based Paper for Skin-like SensingTongfen Liang, Xiyue Zou, Ramendra Kishor Pal, et al.
Investigational New Drugs|March 18, 2015
Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignanciesDavid C Smith, Thea Kalebic, Jeffrey R Infante, et al.
RMD Open|November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung diseaseSangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
Blood|January 17, 2004
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myelomaMelissa Alsina, Rafael Fonseca, Edward F Wilson, et al.
Blood|December 18, 2012
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomibPaul G Richardson, David Siegel, Rachid Baz, et al.
Pageof 13